Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia. [electronic resource]
Producer: 20151019Description: 749-54 p. digitalISSN:- 1465-3621
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Benzamides -- therapeutic use
- CCAAT-Enhancer-Binding Protein-alpha -- metabolism
- Cell Differentiation
- Drug Resistance, Neoplasm
- Female
- Fusion Proteins, bcr-abl -- metabolism
- Humans
- Imatinib Mesylate
- Isoleucine
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Mutation
- Piperazines -- therapeutic use
- Predictive Value of Tests
- Prognosis
- Pyrimidines -- therapeutic use
- Threonine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.